Immunomodulatory effects of copper nanoparticles against mitogen-stimulated rat splenic and thymic lymphocytes
Food and Chemical Toxicology · 2024
DOI: 10.1016/j.fct.2023.114420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Mallaiah Devanabanda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa, 516005, India; Cellular Immunology Laboratory, Department of Biochemi…. Hauptthemen laut MEDLINE: Metal Nanoparticles, Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Ministry of Education, India, National Research Foundation of Korea.
Abstract (Originalsprache)
In the present study, we have evaluated the effects of copper (Cu) nanoparticles (NPs) on the primary B-and T-lymphocytes proliferation, cytokine levels, and bio-distribution through in vitro, in vivo and ex-vivo studies to allow the possible exploitations of CuNPs in biomedical applications. CuNPs were characterized by UV-Visible spectroscopy, transmission electron microscopy (TEM), and nanoparticle tracking analysis (NTA). The proliferative response of lymphocytes was studied by 3H-thymidine incorporation assay and lymphocyte viability through trypan blue assay. The bio-distribution of CuNPs into lymphoid organs was examined by using ex-vivo imaging system. Cytokine levels in plasma of control and CuNPs treated animal groups were determined by enzyme-linked immunosorbent assay (ELISA) method along with other biochemical analysis. CuNPs significantly suppressed the proliferation of primary splenic and thymic lymphocytes in a dose dependent manner. Ex-vivo imaging exhibited the distribution of CuNPs in spleen and thymus. Oral administration of CuNPs (2 mg and 10 mg/kg body weight) significantly inhibited the proliferation of splenic and thymic lymphocytes along with lowered cytokines levels (TNF-alpha and IL-2) on comparison with controls. The results indicated the significant inhibition of lymphocytes proliferative response and secretion of cytokines, thus unveiling the immunomodulatory effects of CuNPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa, 516005, India; Cellular Immunology Laboratory, Department of Biochemistry, School of Life Sciences, University of Hyderabad, Hyderabad, 500…
- School of Chemical Engineering, Yeungnam University, Gyeongsan, 38541, South Korea.
- Cellular Immunology Laboratory, Department of Biochemistry, School of Life Sciences, University of Hyderabad, Hyderabad, 500042, India.
- School of Chemical Engineering, Yeungnam University, Gyeongsan, 38541, South Korea. Electronic address: sckim07@ynu.ac.kr.
- Independent Researcher, W Nazar ST, Boostan Ave, Isfahan, Iran.
- Centre of Excellence for Research in Sustainable Chemistry, Department of Chemistry, Federal University of São Carlos, 13565-905, São Carlos, SP, Brazil.
Förderung
- Ministry of Education, India
- National Research Foundation of Korea
Zitieren
APA
Devanabanda, M., Sana, S. S., Madduri, R., Kim, S. C., Iravani, S., Varma, R. S., & Vadde, R. (2024). Immunomodulatory effects of copper nanoparticles against mitogen-stimulated rat splenic and thymic lymphocytes. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2023.114420
Vancouver
Devanabanda M, Sana SS, Madduri R, Kim SC, Iravani S, Varma RS, et al. Immunomodulatory effects of copper nanoparticles against mitogen-stimulated rat splenic and thymic lymphocytes. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2023.114420
BibTeX
@article{Devanabanda2024,
author = {Devanabanda, Mallaiah and Sana, Siva Sankar and Madduri, Ramanadham and Kim, Seong-Cheol and Iravani, Siavash and Varma, Rajender S and Vadde, Ramakrishna},
title = {Immunomodulatory effects of copper nanoparticles against mitogen-stimulated rat splenic and thymic lymphocytes},
journal = {Food and Chemical Toxicology},
year = {2024},
doi = {10.1016/j.fct.2023.114420}
}
EUVIMED